Skip to main content
Explore URMC

URMC CTSI

menu
TBS Program Director, Members Recognized for Contributions to Community and Research

TBS Program Director, Members Recognized for Contributions to Community and Research

Timothy D. Dye, Ph.D., director of the UR CTSI’s Translational Biomedical Sciences PhD Program and two of the program’s new students, Hanna Murphy and Raven Osborn, received awards at this year’s convocation ceremony. They were recognized for contributions to science and the community, and dedication to diversity, inclusion, and multiculturalism.

Mapping Health: New Data-Sharing Platform Highlights Regional Community Health

Mapping Health: New Data-Sharing Platform Highlights Regional Community Health

Access customized maps and data about our region’s health challenges and resources at the new Roc Health Data website. Researchers and community partners can also register on the site to share their own local health data.   

UR CTSI Co-Director Martin Zand to Lead Clinical Research at URMC

UR CTSI Co-Director Martin Zand to Lead Clinical Research at URMC

Newly appointed Senior Associate Dean for Clinical Research Martin Zand, M.D., Ph.D., hopes to increase the number of high-impact clinical trials at the Medical Center by providing more resources and support for research faculty. 

UR CTSI Joins Effort to Expand Experimental Treatment Access to Desperately Ill Patients

UR CTSI Joins Effort to Expand Experimental Treatment Access to Desperately Ill Patients

The University of Rochester Clinical and Translational Science Institute (UR CTSI) is part of a national effort to help hospitals offer experimental treatments to patients via the FDA’s Expanded Access process and improve how data is tracked from these patients.

Four Ways Academic Organizations Can Boost Clinical Trial Results Reporting

Four Ways Academic Organizations Can Boost Clinical Trial Results Reporting

Academic research organizations struggle to comply with expanding federal requirements for registering and reporting results of clinical trials. Luckily, a recent survey suggests four things organizations can do right now to boost compliance.